CLRB: Cellectar Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 117.24
Enterprise Value ($M) 113.74
Book Value ($M) -1.36
Book Value / Share -0.04
Price / Book -86.46
NCAV ($M) -2.98
NCAV / Share -0.10
Price / NCAV -39.36

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -1.76
Return on Equity (ROE) -2.45

Liquidity (mrq)
Quick Ratio 0.81
Current Ratio 0.81

Balance Sheet (mrq) ($M)
Current Assets 10.45
Assets 12.08
Liabilities 13.43
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -38.96
Net Income -37.98
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -32.38
Cash from Investing -0.86
Cash from Financing 22.94

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Lytton Laurence W 9.99 74.01
02-14 13G/A Rosalind Advisors, Inc. 9.90 50.91
02-14 13G/A Lincoln Park Capital Fund, LLC 9.68 39.41
02-14 13G Nantahala Capital Management, LLC 9.90
02-07 13G/A Hirschman Orin 8.70 39.01
01-31 13G ADAR1 Partners, LP 6.21

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-13 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-14 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-04 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-27 355,223 1,432,087 24.80
2024-03-26 128,444 668,567 19.21
2024-03-25 247,129 1,364,359 18.11
2024-03-22 210,999 1,191,784 17.70

(click for more detail)

Similar Companies
CKPT – Checkpoint Therapeutics, Inc. CLDX – Celldex Therapeutics, Inc.
CLNN – Clene Inc. CLVR – Clever Leaves Holdings Inc.
CMPX – Compass Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io